Neogenomics Inc
NEO- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- SEC CIK
- 0001077183
In the last 90 days, Neogenomics Inc insiders filed 0 open-market purchases and 1 sale; 266 institutions reported holding it in 13F filings for Q2 2026, worth $2.11B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Neogenomics Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 246
- +7 vs. Q2 2022
- Shares held
- 112.6M
- −4.78M (−4.1%) vs. Q2 2022
- Total value
- $969.0M
- +$12.6M (+1.3%) vs. Q2 2022
- New holders
- 38
- 75 more added
- Sold out
- 31
- 86 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NEO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 266 | $2.11B |
| Q1 2026 | 253 | $995.3M |
| Q4 2025 | 257 | $1.54B |
| Q3 2025 | 254 | $995.4M |
| Q2 2025 | 274 | $930.2M |
| Q1 2025 | 256 | $1.20B |
| Q4 2024 | 253 | $2.02B |
| Q3 2024 | 270 | $1.82B |
| Q2 2024 | 259 | $1.74B |
| Q1 2024 | 263 | $2.02B |
| Q4 2023 | 287 | $2.04B |
| Q3 2023 | 284 | $1.48B |
| Q2 2023 | 267 | $1.89B |
| Q1 2023 | 257 | $2.02B |
| Q4 2022 | 244 | $1.04B |
| Q3 2022 | 246 | $969.0M |
| Q2 2022 | 240 | $956.4M |
| Q1 2022 | 281 | $1.36B |
| Q4 2021 | 309 | $4.02B |
| Q3 2021 | 325 | $5.58B |
| Q2 2021 | 313 | $5.03B |
| Q1 2021 | 332 | $5.21B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Neogenomics Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Asset Management Americas Inc | 377,967 | $3.25M | 0.00% | −33,206−8.1% | Reduced |
| HealthCor Management, L.P. | 391,110 | $3.37M | 0.42% | +391,110 | New |
| Eaton Vance Management | 410,828 | $3.54M | 0.01% | −258−0.1% | Reduced |
| Blair William & Co | 552,469 | $4.76M | 0.02% | +263,037+90.9% | Added |
| Nuveen Asset Management, LLC | 565,860 | $4.87M | 0.00% | −482,110−46.0% | Reduced |
| D. E. Shaw & Co., Inc. | 633,201 | $5.45M | 0.01% | −375,885−37.3% | Reduced |
| Voloridge Investment Management, LLC | 663,882 | $5.72M | 0.03% | −419,627−38.7% | Reduced |
| Bank of America Corp | 665,476 | $5.73M | 0.00% | −14,489−2.1% | Reduced |
| Millennium Management LLC | 674,637 | $5.81M | 0.01% | −1,489,626−68.8% | Reduced |
| Two Sigma Investments, LP | 677,199 | $5.83M | 0.02% | −782,858−53.6% | Reduced |
| Price T Rowe Associates Inc | 727,588 | $6.27M | 0.00% | −844,425−53.7% | Reduced |
| Royce & Associates LP | 766,750 | $6.60M | 0.07% | +170,300+28.6% | Added |
| Emerald Mutual Fund Advisers Trust | 768,186 | $6.61M | 0.42% | −191,672−20.0% | Reduced |
| Principal Financial Group Inc | 788,854 | $6.79M | 0.01% | +5,564+0.7% | Added |
| Charles Schwab Investment Management Inc | 945,830 | $8.14M | 0.00% | +12,583+1.3% | Added |
| Dimensional Fund Advisors LP | 973,871 | $8.38M | 0.00% | −250,303−20.4% | Reduced |
| Two Sigma Advisers, LP | 1,042,700 | $8.98M | 0.03% | −143,200−12.1% | Reduced |
| JPMorgan Chase & Co | 1,067,207 | $9.19M | 0.00% | +815,539+324.1% | Added |
| Bank of New York Mellon Corp | 1,103,581 | $9.50M | 0.00% | +50,410+4.8% | Added |
| Segall Bryant & Hamill, LLC | 1,111,874 | $9.58M | 0.11% | +1,111,874 | New |
| Norges Bank | 1,186,214 | $10.2M | 0.00% | +119,917+11.2% | Added |
| Citadel Advisors LLC | 1,226,483 | $10.6M | 0.01% | +276,458+29.1% | Added |
| Ameriprise Financial Inc | 1,247,715 | $10.7M | 0.00% | +589,695+89.6% | Added |
| Glenmede Trust Co NA | 1,257,286 | $10.8M | 0.07% | +72,615+6.1% | Added |
| Invesco Ltd. | 1,316,293 | $11.3M | 0.00% | −23,755−1.8% | Reduced |
| Franklin Resources Inc | 1,401,601 | $12.1M | 0.01% | +17,844+1.3% | Added |
| Kopp Family Office, LLC | 1,539,113 | $13.3M | 10.79% | −76,400−4.7% | Reduced |
| Morgan Stanley | 1,544,640 | $13.3M | 0.00% | +227,032+17.2% | Added |
| Fred Alger Management, LLC | 1,633,904 | $14.1M | 0.07% | +1,060,294+184.8% | Added |
| Northern Trust Corp | 1,641,073 | $14.1M | 0.00% | +382,486+30.4% | Added |
| Schroder Investment Management Group | 1,727,572 | $14.9M | 0.02% | −568,111−24.7% | Reduced |
| Macquarie Group Ltd | 1,918,276 | $16.5M | 0.02% | +33,262+1.8% | Added |
| Greenhouse Funds LLLP | 2,009,868 | $17.3M | 2.02% | +614,833+44.1% | Added |
| Federated Hermes, Inc. | 2,073,414 | $17.9M | 0.05% | −602,622−22.5% | Reduced |
| Emerald Advisers, LLC | 2,139,579 | $18.4M | 0.95% | +926,226+76.3% | Added |
| Geode Capital Management, LLC | 2,349,513 | $20.2M | 0.00% | +102,117+4.5% | Added |
| T. Rowe Price Investment Management, Inc. | 2,568,909 | $22.1M | 0.02% | +2,568,909 | New |
| Goldman Sachs Group Inc | 2,649,916 | $22.8M | 0.01% | −765,479−22.4% | Reduced |
| First Light Asset Management, LLC | 2,720,099 | $23.4M | 2.37% | +4,612+0.2% | Added |
| Wellington Management Group LLP | 3,208,459 | $27.6M | 0.01% | −3,314,209−50.8% | Reduced |
| State Street Corp | 4,217,160 | $36.3M | 0.00% | +116,802+2.8% | Added |
| Janus Henderson Group PLC | 5,961,144 | $51.3M | 0.04% | +4,915,452+470.1% | Added |
| Brown Advisory Inc | 6,180,735 | $53.2M | 0.10% | +413,085+7.2% | Added |
| Vanguard Group Inc | 13,174,708 | $113.4M | 0.00% | −141,693−1.1% | Reduced |
| BlackRock Inc. | 21,109,182 | $181.8M | 0.01% | +79,055+0.4% | Added |
| Sofos Investments, Inc. | 27 | – | – | −3−10.0% | Reduced |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −3,611,674−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −2,075,433−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −206,021−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −153,265−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −135,573−100.0% | Sold out |
| Natixis Investment Managers International | 0 | $0 | 0.00% | −77,607−100.0% | Sold out |
| Maryland State Retirement & Pension System | 0 | $0 | 0.00% | −49,937−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −40,477−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −40,146−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −39,626−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −32,209−100.0% | Sold out |
| Gamco Investors, Inc. Et Al | 0 | $0 | 0.00% | −30,510−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −28,323−100.0% | Sold out |
| Parametrica Management Ltd | 0 | $0 | 0.00% | −15,432−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −13,530−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −12,261−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −11,592−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −11,417−100.0% | Sold out |
| GAM Holding AG | 0 | $0 | 0.00% | −10,689−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −5,650−100.0% | Sold out |
| Security Benefit Life Insurance Co | 0 | $0 | 0.00% | −5,387−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −2,478−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −393−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −249−100.0% | Sold out |
| Curi Capital | 0 | $0 | 0.00% | −193−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −217−100.0% | Sold out |
| Heritage Financial Services, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| Sageworth Trust Co of South Dakota | 0 | $0 | 0.00% | −68−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Level Financial Advisors, Inc. | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Exane Derivatives | – | – | – | – | Not filed |